Korean J Gastroenterol.  2018 Jun;71(6):338-348. 10.4166/kjg.2018.71.6.338.

Gastrointestinal cancer risk in patients with a family history of gastrointestinal cancer

Affiliations
  • 1Division of Gastroenterology, National Medical Center, Seoul, Korea.
  • 2Department of Medicine, The Graduate School, Yonsei University, Seoul, Korea.
  • 3Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Korea. drlimyj@gmail.com
  • 4Department of Internal Medicine, Chosun University College of Medicine, Gwangju, Korea.
  • 5Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea.
  • 6Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Korea.
  • 7Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Korea.
  • 8Department of Gastroenterology, Myongji Hospital, Goyang, Korea.
  • 9Department of Gastroenterology, Wonkwang University Hospital, Iksan, Korea.

Abstract

BACKGROUND/AIMS
This study was performed to evaluate the relationship between family history of gastrointestinal (GI) cancers and incidence of any GI cancer in the Korean population.
METHODS
Between January 2015 and July 2016, 711 GI cancer patients and 849 controls in 16 hospitals in Korea were enrolled. Personal medical histories, life styles, and family history of GI cancers were collected via questionnaire.
RESULTS
There was a significant difference in the incidence of family history of GI cancer between GI cancer patients and controls (p=0.002). Patients with family history of GI cancer tended to be diagnosed as GI cancer at younger age than those without family history (p=0.016). The family members of GI cancer patients who were diagnosed before 50 years of age were more frequently diagnosed as GI cancer before the age of 50 years (p=0.017). After adjusting for major confounding factors, age (adjusted odds ratio [AOR] 1.065, 95% confidence interval [CI]; 1.053-1.076), male gender (AOR 2.270, 95% CI; 1.618-3.184), smoking (AOR 1.570, 95% CI; 1.130-2.182), and sibling's history of GI cancer (AOR 1.973, 95% CI; 1.246-3.126) remained independently associated with GI cancers.
CONCLUSIONS
GI cancer patients tended to have a first relative with a history of concordant GI cancer. Personal factors (old age and male) and lifestyle (smoking) contribute to the development of GI cancer, independently. Individuals with high risk for GI cancers may be advised to undergo screening at an earlier age.

Keyword

Gastrointestinal neoplasm; Medical history taking; Risk factors

MeSH Terms

Age Factors
Gastrointestinal Neoplasms*
Humans
Incidence
Korea
Life Style
Male
Mass Screening
Medical History Taking
Odds Ratio
Risk Factors
Smoke
Smoking
Smoke

Reference

References

1. Bhat GA, Shah IA, Rafiq R, et al. Family history of cancer and the risk of squamous cell carcinoma of oesophagus: a casecontrol study in Kashmir, India. Br J Cancer. 2015; 113:524–532.
Article
2. Shin CM, Kim N, Yang HJ, et al. Stomach cancer risk in gastric cancer relatives: interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer. J Clin Gastroenterol. 2010; 44:e34–39.
3. Johns LE, Houlston RS. A systematic review and metaanalysis of familial colorectal cancer risk. Am J Gastroenterol. 2001; 96:2992–3003.
Article
4. Hassan MM, Spitz MR, Thomas MB, et al. The association of family history of liver cancer with hepatocellular carcinoma: a casecontrol study in the United States. J Hepatol. 2009; 50:334–341.
Article
5. Fehringer G, Gallinger S, Borgida A, et al. The association of family history of cancer and medical history with pancreatic cancer risk. Pancreas. 2014; 43:812–814.
Article
6. Turati F, Edefonti V, Bosetti C, et al. Family history of cancer and the risk of cancer: a network of casecontrol studies. Ann Oncol. 2013; 24:2651–2656.
Article
7. Hemminki K, Li X. Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden. Int J Cancer. 2003; 103:525–530.
Article
8. Hoar SK, Wilson J, Blot WJ, McLaughlin JK, Winn DM, Kantor AF. Second cancer following cancer of the digestive system in Connecticut, 1935–82. Natl Cancer Inst Monogr. 1985; 68:49–82.
9. Rahimi E, Batra S, Thosani N, Singh H, Guha S. Increased incidence of second primary pancreatic cancer in patients with prior colorectal cancer: a population-based US study. Dig Dis Sci. 2016; 61:1652–1660.
Article
10. Stoffel EM. Screening in GI cancers: the role of genetics. J Clin Oncol. 2015; 33:1721–1728.
Article
11. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science. 2013; 339:1546–1558.
Article
12. Chun N, Ford JM. Genetic testing by cancer site: stomach. Cancer J. 2012; 18:355–363.
13. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014; 513:202–209.
14. Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastroenterology. 2010; 138:2044–2058.
Article
15. Kastrinos F, Mukherjee B, Tayob N, et al. Risk of pancreatic cancer in families with Lynch syndrome. JAMA. 2009; 302:1790–1795.
Article
16. Giardiello FM, Offerhaus GJ, Lee DH, et al. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut. 1993; 34:1394–1396.
Article
17. Lowenfels AB, Maisonneuve P, DiMagno EP, et al. Hereditary pancreatitis and the risk of pancreatic cancer. International hereditary pancreatitis study group. J Natl Cancer Inst. 1997; 89:442–446.
18. Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology. 2000; 119:1447–1453.
Article
19. de Snoo FA, Bishop DT, Bergman W, et al. Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families. Clin Cancer Res. 2008; 14:7151–7157.
Article
20. Bruenderman EH, Martin RC 2nd. High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening. J Surg Res. 2015; 194:212–219.
Article
21. Lakatos G, Balázs A, Kui B, et al. Pancreatic cancer: multicenter prospective data collection and analysis by the hungarian pancreatic study group. J Gastrointestin Liver Dis. 2016; 25:219–225.
Article
22. Klein AP, Brune KA, Petersen GM, et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res. 2004; 64:2634–2638.
Article
23. Schneider R, Slater EP, Sina M, et al. German national case collection for familial pancreatic cancer (FaPaCa): ten years experience. Fam Cancer. 2011; 10:323–330.
Article
24. Wu M, Zhang ZF, Kampman E, et al. Does family history of cancer modify the effects of lifestyle risk factors on esophageal cancer? A population-based casecontrol study in China. Int J Cancer. 2011; 128:2147–2157.
Article
25. Kwak HW, Choi IJ, Kim CG, et al. Individual having a parent with early-onset gastric cancer may need screening at younger age. World J Gastroenterol. 2015; 21:4592–4598.
Article
26. Henrikson NB, Webber EM, Goddard KA, et al. Family history and the natural history of colorectal cancer: systematic review. Genet Med. 2015; 17:702–712.
Article
27. Samadder NJ, Curtin K, Tuohy TM, et al. Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah. Gastroenterology. 2014; 147:814–821. e5; quiz e15-e16.
Article
28. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US multisociety task force on colorectal cancer, and the American college of radiology. Gastroenterology. 2008; 134:1570–1595.
Article
29. Park CH, Jeong SH, Yim HW, et al. Family history influences the early onset of hepatocellular carcinoma. World J Gastroenterol. 2012; 18:2661–2667.
Article
30. Choi YS, Suh JP, Lee DS, et al. Colonoscopy screening for individuals aged 40–49 years with a family history of stomach cancer in Korea. Int J Colorectal Dis. 2010; 25:443–447.
31. Ouakrim DA, Boussioutas A, Lockett T, Hopper JL, Jenkins MA. Cost-effectiveness of family history-based colorectal cancer screening in Australia. BMC Cancer. 2014; 14:261.
Article
32. Liu J, Shu T, Chang S, Sun P, Zhu H, Li H. Risk of malignancy associated with a maternal family history of cancer. Asian Pac J Cancer Prev. 2014; 15:2039–2044.
Article
33. Cameron E, Rose S, Carey M. Assessment of family history of colorectal cancer in primary care: perceptions of first degree relatives of people with colorectal cancer. Patient Educ Couns. 2014; 94:427–431.
Article
34. Wood ME, Kadlubek P, Pham TH, et al. Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology quality oncology practice initiative. J Clin Oncol. 2014; 32:824–829.
Article
35. Qureshi N, Wilson B, Santaguida P, et al. Collection and use of cancer family history in primary care. Evid Rep Technol Assess (Full Rep). 2007; (159):1–84.
36. Fiederling J, Shams AZ, Haug U. Validity of self-reported family history of cancer: a systematic literature review on selected cancers. Int J Cancer. 2016; 139:1449–1460.
Article
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr